Advertisement

Topics

Keen-Summit Capital Partners Company Profile

22:51 EST 23rd February 2019 | BioPortfolio

Keen-Summit Capital Partners LLC, located in New York, provides real estate analysis, valuation and strategic planning services, brokerage, M&A, auction services, lease restructuring services and real estate capital market services. For more information about Keen-Summit Capital Partners, call 646-381-9222 or visit http://www.Keen-Summit.com.


News Articles [1734 Associated News Articles listed on BioPortfolio]

Summit well-funded as it gears up for ridinilazole phase III trial early next year

Summit has £13.0mln in the bank, while its drugs have also been backed financially by external organisations keen to see new treatments come through

Deals this week: Sitryx, Keen Eye, Accera

Sitryx has raised $30m in a Series A financing round led by SV Health Investors and Sofinnova Partners. The funds...Read More... The post Deals this week: Sitryx, Keen Eye, Accera appeared first on Dr...

Bob Duggan: Meet the US biotech billionaire taking a 49% stake in Summit

Duggan is said to be keen to finance the development of new antibiotics, with many viruses becoming increasingly resistant to the current cohort already out there

Abris Capital Partners vend Urgent Cargus, le nº 2 de la livraison express en Roumanie

VARSOVIE, Pologne, September 27, 2018 /PRNewswire/ -- Abris Capital Partners, gestionnaire de fonds de capital-investissement privé d'Europe centrale et de l'Est, a vendu 100 % Read more...

Medigene: Leerverkäufer GSA Capital Partners hat sich deutlich zurückgezogen

Martinsried (www.aktiencheck.de) - Leerverkäufer GSA Capital Partners LLP verringert Netto-Leerverkaufsposition in Medigene-Aktien signifikant: Die Leerverkäufer des Hedgefonds GSA Capital Partners....

Glilot Capital Partners Raises $110 Million for Its Third Fund

TEL AVIV, Israel, Oct. 15, 2018 /PRNewswire/ -- Glilot Capital Partners a Venture capital fund which invests in early-stage startups, has announced the closing of Read more...

M&As this week: Ampersand Capital Partners, Bioblast Pharma, Synteract

Ampersand Capital Partners has acquired and merged biomarker testing services provide Pacific Biomarkers into its existing portfolio company, NEOMED-LABS. The...Read More... The post M&As this we...

CNS-focused Arvelle spins off from Axovant with planned $100mm initial round

Axovant Sciences Ltd. spun off its small-molecule platform assets into a new company, Arvelle Therapeutics GMBH, which received commitments for an initial capital raise of over $100mm (assumed to be i...

PubMed Articles [403 Associated PubMed Articles listed on BioPortfolio]

Palliative Nursing Summit: Nurses Leading Change and Transforming Care: Our Journey to the Summit.

The Hospice and Palliative Nurses Association, in conjunction with the Hospice and Palliative Credentialing Center and the Hospice and Palliative Nurses Foundation, organized a Palliative Nursing Summ...

Relationship between social capital and happiness in a Japanese community - a cross-sectional study.

The influence of social capital on happiness is attracting attention around the world. Many studies that investigated the relationship between social capital and happiness suggest that happiness corre...

Community-based structural social capital and depressive symptoms of older urban Chinese adults: The mediating role of cognitive social capital.

The present study aimed to investigate the mediating role of cognitive social capital in the association between community-based structural social capital and depressive symptoms among older adults li...

Capital Gains: Attracting Investors Without Losing Independence.

Can physicians line up venture capital without letting go of their independence? It's not so easy.

Association between social capital and second dose of measles vaccination in Japan: Results from the A-CHILD study.

Measles vaccination is important to prevent outbreak, and social capital can be an important preventive factor. However, there have been very few studies that investigated the association between soci...

Clinical Trials [420 Associated Clinical Trials listed on BioPortfolio]

Clinical Study Comparing Two Implant Surface Finishes in Patients Undergoing Cementless Total Hip Replacement

Prospective, randomized study of Summit Porocoat versus Summit DuoFix HA in total hip arthroplasty

Social Capital and Engagement in Care Among Young Black Men Who Have Sex With Men Living With HIV

The study is a randomized controlled trial to evaluate the social capital intervention versus a general health promotion intervention (Health for Life; H4L) among groups of Young black men...

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School RCT

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Companies [2020 Associated Companies listed on BioPortfolio]

Keen-Summit Capital Partners

Keen-Summit Capital Partners LLC, located in New York, provides real estate analysis, valuation and strategic planning services, brokerage, M&A, auction services, lease restructur...

Summit Partners

At Summit Partners, we understand the challenges of building a successful company because we have done it ourselves.In 1984, we started the firm with a vision of helping profitable companies realize t...

Summit Health

Founded in 1999, Summit Health is now the nation's highest rated provider of on-site wellness programs, including health screenings, immunizations, coaching, and educational seminars. This focus on qu...

Summit Corporation plc

Summit is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadeq...

Oak Hill Capital Partners

Oak Hill Capital Partners is a private equity firm with more than $8.2 billion of committed capital from leading entrepreneurs, endowments, foundations, corporations, pension fund...

More Information about "Keen-Summit Capital Partners" on BioPortfolio

We have published hundreds of Keen-Summit Capital Partners news stories on BioPortfolio along with dozens of Keen-Summit Capital Partners Clinical Trials and PubMed Articles about Keen-Summit Capital Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Keen-Summit Capital Partners Companies in our database. You can also find out about relevant Keen-Summit Capital Partners Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record